Cargando…

Omalizumab in patients with severe asthma and persistent sputum eosinophilia

Omalizumab, a recombinant humanized monoclonal antibody targeting the IgE molecule, is the first biologic approved for moderate-to-severe allergic asthmatics, who remain uncontrolled despite high dose inhaled corticosteroid and bronchodilators. Steroid-sparing effect of omalizumab has not been demon...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mukherjee, Manali, Kjarsgaard, Melanie, Radford, Katherine, Huang, Chynna, Leigh, Richard, Dorscheid, Delbert R., Lemiere, Catherine, Boulet, Louis-Philippe, Waserman, Susan, Martin, James, Nair, Parameswaran
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6448265/ https://www.ncbi.nlm.nih.gov/pubmed/30988677 http://dx.doi.org/10.1186/s13223-019-0337-2

Ejemplares similares

Underestimation of airway luminal eosinophilia by quantitative sputum cytometry
por: Kjarsgaard, Melanie, et al.
Publicado: (2021)

A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer
por: Ali, M. Monsur, et al.
Publicado: (2022)

Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy
por: Wang, Hongyu, et al.
Publicado: (2018)

Iron in airway macrophages and infective exacerbations of chronic obstructive pulmonary disease
por: Ho, Terence, et al.
Publicado: (2022)

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV(1) and eosinophilic exacerbations
por: Aziz-Ur-Rehman, Afia, et al.
Publicado: (2017)

Hemosiderin in sputum macrophages may predict infective exacerbations of chronic obstructive pulmonary disease: a retrospective observational study
por: Mohan, Sindu, et al.
Publicado: (2017)

Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy
por: Mukherjee, Manali, et al.
Publicado: (2017)

Autoimmune Responses in Severe Asthma
por: Mukherjee, Manali, et al.
Publicado: (2018)

CFTR heterozygosity in severe asthma with recurrent airway infections: a retrospective review
por: Priel, Eldar, et al.
Publicado: (2022)

Changes in blood eosinophilia during omalizumab therapy as a predictor of asthma exacerbation
por: Skiepko, Roman, et al.
Publicado: (2014)

Inhaled Corticosteroids and Adult Asthma
por: Boulet, Louis-Philippe, et al.
Publicado: (2019)

Anti-IL5 therapy for asthma and beyond
por: Mukherjee, Manali, et al.
Publicado: (2014)

Autoinflammatory gene mutations associated with eosinophilia and asthma
por: Alotaibi, Bashayr M., et al.
Publicado: (2023)

Further Observations on Cases of Asthma and Bronchitis Associated with High Eosinophilia and with Mites in the Sputum
por: D'Abrera, V. St. E.
Publicado: (1946)

Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia
por: Crespo-Lessmann, Astrid, et al.
Publicado: (2023)

Monitoring eosinophils to guide therapy with biologics in asthma: does the compartment matter?
por: Koenderman, Leo, et al.
Publicado: (2020)

Evaluation of asthma severity: Relevance of total serum IgE, sputum and peripheral eosinophilia
por: Mahesh, PA
Publicado: (2017)

Characteristics of Induced-Sputum Inflammatory Phenotypes in Adults with Asthma: Predictors of Bronchial Eosinophilia [Corrigendum]
Publicado: (2023)

Effectiveness of omalizumab in an asthmatic patient with severe airway and blood eosinophilia
por: Kupryś-Lipińska, Izabela, et al.
Publicado: (2015)

Sputum eosinophilia is a determinant of FEV1 decline in occupational asthma: results of an observational study
por: Talini, Donatella, et al.
Publicado: (2015)

Eosinophilia and Response to Bronchial Thermoplasty
por: Svenningsen, Sarah, et al.
Publicado: (2021)

The Allergic Rhinitis Clinical Investigator Collaborative – nasal allergen induced eosinophilia
por: Thiele, Jenny, et al.
Publicado: (2014)

Modulation of human airway smooth muscle biology by human adipocytes
por: Giesler, Amanda, et al.
Publicado: (2018)

Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma
por: Kitaguchi, Yoshiaki, et al.
Publicado: (2012)

A novel assay for improved detection of sputum periostin in patients with asthma
por: Ono, Junya, et al.
Publicado: (2023)

Circulating anti-nuclear autoantibodies in COVID-19 survivors predict long-COVID symptoms
por: Son, Kiho, et al.
Publicado: (2022)

Protocol: Influence of Budesonide and Budesonide/Formoterol on Asthma Control in Smoking Asthmatic Adults
por: Boulet, Louis-Philippe, et al.
Publicado: (2010)

280 Use of Omalizumab in Chronic Moderate to Severe Persistent Asthma-an Indian Experience
por: Ansari, Qamar, et al.
Publicado: (2012)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Guidance for Administering Biologics for Severe Asthma and Allergic Conditions
por: Dorscheid, Delbert R., et al.
Publicado: (2022)

Asymptomatic Esophageal Eosinophilia in an 11-Year-Old with Severe Persistent Asthma
por: Hofstaedter, Casey E., et al.
Publicado: (2023)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

Benralizumab in severe eosinophilic asthma in real life: confirmed effectiveness and contrasted effect on sputum eosinophilia versus exhaled nitric oxide fraction – PROMISE
por: Schleich, Florence, et al.
Publicado: (2023)

The dynamics of the manifestations of atopic dermatitis in severe persistent uncontrolled asthma children with omalizumab therapy
por: Vishneva, Elena, et al.
Publicado: (2015)

Omalizumab: Clinical Use for the Management of Asthma
por: Thomson, Neil C., et al.
Publicado: (2012)

PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab
por: Vilella, Mireia, et al.
Publicado: (2014)

Sputum IgE and Cytokines in Asthma: Relationship with Sputum Cellular Profile
por: Manise, Maïté, et al.
Publicado: (2013)

Understanding the roles of the transcription factors nuclear factor-κB and hypoxia-inducible factor-1α in lung injury
por: Craig, Katherine, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_jtn22vvnq4vgl4n8ujspp5lurg